Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials

INTRODUCTION: In the early stage of schizophrenia (first 5 years), the most important clinical target besides symptom control is relapse prevention as each relapse significantly decreases the possibility of preferable long-term outcomes. Early discontinuation of antipsychotic medication due to intol...

Descripción completa

Detalles Bibliográficos
Autores principales: Dombi, Z.B., Acsai, K., Barabássy, Á., Sebe, B., Laszlovszky, I., Vass, G., Szatmári, B., Patel, M., Earley, W., Németh, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475661/
http://dx.doi.org/10.1192/j.eurpsy.2021.1400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475661/
http://dx.doi.org/10.1192/j.eurpsy.2021.1400

Ejemplares similares